Search

everythinglearnresearchcommunity

for

Search:↓

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

A woman's nail separation was likely caused by poor blood flow, and a treatment for similar conditions might help.

Surgery on a baby with a skin disorder improved eyelid position and eye health.

Dermatological conditions are complex and treatments often have mixed results.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Ginger hair tonic can reduce hair loss and improve hair quality.

Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Dermoscopy is underused in aesthetic medicine, but it increases diagnostic confidence, and professionals need more training.

Dermoscopy is underused in aesthetic medicine, but it increases diagnosis confidence; more training is needed.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Herbal treatments can help with early-stage BPH symptoms, but more research is needed.

Men with enlarged prostates often have more severe baldness.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Early hair loss may indicate prostate issues.